Yiming Zhao
About Yiming Zhao
Yiming Zhao is the Director of RNA Therapeutics and Drug Delivery at BeiGene in New York, with extensive experience in protein therapeutics, long-acting injectables, and nanomaterials. He has authored over 25 publications and is the main inventor on 4 US patent applications.
Title
Director, RNA Therapeutics and Drug Delivery at BeiGene
Current Position at BeiGene
Yiming Zhao currently holds the position of Director of RNA Therapeutics and Drug Delivery at BeiGene, located in New York, United States.
Previous Roles at Regeneron
Yiming Zhao worked at Regeneron as a Staff Scientist in Lipid Nanoparticle and Biologics Formulation from 2021 to 2022. Prior to this, Zhao served as a Scientist in Formulation Development from 2017 to 2020.
Research Experience at Memorial Sloan-Kettering Cancer Center
From 2014 to 2017, Yiming Zhao worked at Memorial Sloan-Kettering Cancer Center as a Visiting Investigator. This role involved extensive research in the Greater New York City Area.
Educational Background
Yiming Zhao holds a Ph.D. from Utrecht University, where Zhao studied Luminescent materials for bioapplications from 2009 to 2013. Zhao also earned an MSc in Polymer Chemistry from the University of Helsinki between 2006 and 2008, and a BSc in Chemistry from Wuhan University, completed in 2007.
Patent Contributions
Yiming Zhao is the main inventor on four US patent applications and has filed three patents related to a novel anhydrous emulsion method for the microencapsulation of therapeutic proteins.
Publications
Yiming Zhao has authored over 25 academic publications, with Zhao being the first or coordinating author on nine of them.
Technical Expertise
Yiming Zhao possesses extensive experience in analytical method development, formulation, and process development. Zhao applies Quality by Design (QbD) principles and supports analytical needs for formulation and process development, working closely with QC and regulatory teams.
Experience in Nanoparticles and Protein Therapeutics
Yiming Zhao has significant expertise in the characterization of protein therapeutics, long-acting injectables, and nanomaterials. Zhao has developed a novel anhydrous emulsion method for microencapsulation of therapeutic proteins, providing high protein stability.
Leadership and Coordination Skills
Yiming Zhao has demonstrated technical leadership skills, including mentoring and managing teams. Zhao has coordinated cross-functional projects and communicated effectively with external vendors, Contract Development and Manufacturing Organizations (CDMOs), and technology partners.